FDA Finalizes Montelukast Black Box Warning
Agency approves label changes after reports of neuropsychiatric events WASHINGTON — The FDA...
Read More
BreakingMed
Severe Acute Brain Injury: Value and Goals of Decision Makers
Survey data identify groups with differing priorities Surrogate decision makers who were asked...
Read More
Covid-19: QT Prolongation Common in Patients Treated with Malaria Drug
Two studies add to concerns about hydroxychloroquine safety Two studies published Friday raised...
Read MoreFacioscapulohumeral Muscular Dystrophy Phenotypic Variation Identified
Study ’brings FSHD back to the clinic’ Knowing the phenotypic variations in facioscapulohumeral muscular dystrophy (FSHD) can help clinicians better manage the disease and offer more informed genetic counseling,...
Read More
SGO: Improved Outcomes with Olaparib Added to Bevacizumab Maintenance in Ovarian Ca
Best results were seen with complete debulking during upfront surgery Adding the PARP inhibitor...
Read More
Burning Mouth Syndrome Associated with Increased Risk of Depression, Anxiety
Women were more likely than men to have the condition as were patients over age 64 A chronic oral...
Read More
Conflicting Data on Remdesivir for Covid-19 Highlight Efficacy Questions
Drug shows promise in an unpublished trial, but no benefit in first peer-reviewed clinical trial...
Read More
Covid-19: Contact Tracing Will Take An Army of Disease Detectives
Experts warn ’time is of the essence’ to put contact tracers in place It will take an army of...
Read More
NT-proBNP: Is It a Reliable Prognostic Marker in HFpEF?
Biomarker predicts outcome but no effect on ARNI efficacy When the findings from the PARAGON-HF...
Read More
Oral Tx Option for Psoriatic Arthritis Improves Dermatologic Signs, QoL
Tofacitinib leads to lasting improvements in dermatologic symptoms in OPAL Broaden and OPAL Beyond...
Read More
Covid-19: When the President Speaks, People Listen, and Google Answers
Google searches for hydroxychloroquine surged following endorsement When presidents and other...
Read More
PARP Inhibitor Demonstrates Efficacy in Castration-Resistant Prostate Cancer
Greatest benefit in BRCA1 and BRCA2 alterations Among men with castration-resistant, metastatic...
Read More
Covid-19: AMA Wants Feds to Take Charge
National testing strategy needed now The U.S. now has more than one million Covid-19 cases,...
Read More
Covid-19: Asymptomatic Transmission Fueled Nursing Home Death Toll
More than half who tested positive had no symptoms In a Seattle-area nursing home that was hit...
Read More
Clopidogrel a Better Option for Older Patients with Non-ST-Segment-Elevation ACS
Reduces bleeding risk compared to stronger P2Y12 inhibitors It appears a “less is...
Read More
Danish Registry Links Mental Disorders to Risk of Medical Conditions
Overall mental disorder diagnosis may increase likelihood of medical diagnoses Most, but not all,...
Read More
OXVASC: Symptomatic Intracranial Stenosis Stroke Risk in Older Cohort Similar to Previous Trials
Nonsuperiority of stenting SAMMPRIS, VISSIT conclusions may generalize to older cohort Medical...
Read MorePoison Control: Managing the Clinical Trajectory of Caustic Ingestions
Children’s poisonings are usually exploratory in intent, while adults are often due to self-harm There’s been an uptick in calls to poison control centers around the country ever since President Donald Trump asked...
Read More
Evolocumab Continues to Prove Mettle in High-Risk Heart Patients
Pre-specified analyses of FOURIER trial look at impact on aortic valve stenosis, MI Higher...
Read More
Covid-19: Topline Results Suggest Remdesivir Effective in Hospitalized Patients
5-day regimen as effective as 10-day Tx Topline results from an open-label phase III trial of the...
Read More